We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

40 hedge funds and large institutions have $89.7M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 2

122% more funds holding

Funds holding: 18 → 40 (+22)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

99% more capital invested

Capital invested by funds: $45.1M → $89.7M (+$44.7M)

Holders
40
Holders Change
+22
Holders Change %
+122.22%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
4
Reduced
2
Closed
2
Calls
$200K
Puts
–
Net Calls
+$200K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
GL
Governors Lane
New York
+$4.86M
2
PC
Periscope Capital
Ontario, Canada
+$3.98M
3
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$3.72M
4
SCM
Shaolin Capital Management
Florida
+$3.47M
5
UOC
UBS O'Connor
Illinois
+$3.13M

Top Sellers

Rank Fund Capital Flow
1
OCM
Oaktree Capital Management
California
-$2.5M
2
FLC
Fifth Lane Capital
Texas
-$986K
3
WAM
Wolverine Asset Management
Illinois
-$784K
4
SV
Starboard Value
New York
-$61K

LVAC Hedge Fund Activity: Q1 2022 in Review

40 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q1 2022, worth a combined $89.7M — up 99% from $45.1M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new LVAC positions and 2 closed out — a net gain of 22 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Governors Lane, opening a new position worth an estimated $4.86M. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $2.5M sold.

  • 40 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q1 2022, up from 18 in Q4 2021.
  • Funds reported $89.7M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q1 2022, up 99% quarter-over-quarter.
  • 24 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +22 holders.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q1 2022 was Governors Lane, an estimated $4.86M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q1 2022 was Oaktree Capital Management, an estimated $2.5M sold.

Based on aggregated 13F filings for Q1 2022.